Saniona AB (Sweden) Today

SANION Stock  SEK 7.86  1.05  15.42%   

Performance

11 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 30

 
High
 
Low
Below Average
Saniona AB is trading at 7.86 as of the 31st of January 2025, a 15.42 percent increase since the beginning of the trading day. The stock's open price was 6.81. Saniona AB has about a 30 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. The company has 62.39 M outstanding shares. More on Saniona AB

Moving against Saniona Stock

  0.7EVO Evolution ABPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Saniona Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Saniona AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Saniona AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationHealth Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Saniona AB (SANION) is traded on Stockholm Exchange in Sweden and employs 25 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 196.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Saniona AB's market, we take the total number of its shares issued and multiply it by Saniona AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Saniona AB operates under Biotechnology sector and is part of Health Care industry. The entity has 62.39 M outstanding shares. Saniona AB has accumulated about 356.86 M in cash with (345.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96.
Check Saniona AB Probability Of Bankruptcy
Ownership Allocation
Saniona AB shows a total of 62.39 Million outstanding shares. Saniona AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Saniona Ownership Details

Saniona AB Risk Profiles

Although Saniona AB's alpha and beta are two of the key measurements used to evaluate Saniona AB's performance over the market, the standard measures of volatility play an important role as well.

Saniona Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Saniona AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Saniona AB Corporate Management

Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Karin NielsenChief OfficerProfile
Rami LevinPresidentProfile
Palle MSEx ResearchProfile
Anita BComChief OfficerProfile
Janus LarsenChief OfficerProfile
MBA MScCoFounder CEOProfile
Jorgen DrejerChairman FounderProfile

Other Information on Investing in Saniona Stock

Saniona AB financial ratios help investors to determine whether Saniona Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Saniona with respect to the benefits of owning Saniona AB security.